A pan-cancer, pan-Canadian Precision OncologyPlatform at the MUHC ($25M)
Dr. Lorenzo Ferri
A pan-cancer, pan-Canadian Precision Oncology
Platform at the MUHC ($25M)
The current trial-and-error approach to chemotherapy drug selection unnecessarily exposes a significant proportion of patients to toxic drugs which don’t work for them. To replace this, Dr. Lorenzo Ferri and his team at the MGH grow a replica of your tumour in the lab and test hundreds of drugs on it to identify the most effective treatment for your specific tumour. His lab team have a five year plan to shorten and perfect the process, gain approval for use as the new standard of care for esophageal and gastric cancers, then to expand to multiple other types of cancer, while serving cancer
centres across Canada.
“You can help us usher in a new era of precision, personalized cancer treatments.”
Dr. Lorenzo Ferri
Director, Division of Thoracic Surgery
Tumor-on-a chip technology, used by Dr. Ferri to idenify the best drugs to combat cancer.
Steve Paulette, a patient of Dr. Ferri, survived Stage-4 esophageal cancer.
More news
$80M Raised So Far, Thanks to You
From offering patients whole-person care to equalizing access to clinical trials, and more, the life-changing projects supported by Together Against Cancer are already improving patient experiences and outcomes.
Alex’s Story: Philanthropy That Saves Lives
In October 2021, Alex Villalta’s cardiologist noticed that Alex had lost a lot of weight in a very short time, and he was concerned. Alex was referred to the Cedars Cancer Centre at the McGill University Health Centre (MUHC), where, just 18 days later, he received a devastating diagnosis.
Giving Patients Back What Cancer Took Away
Plastic surgeon Dr. Josh Vorstenbosch, Director of the McGill University Health Centre (MUHC)’s Surgical Lymphedema Program, wants to “give patients back what cancer took away,” he says.